Putting economic interests over public health is leading the world towards three slow-motion health disasters, Margaret Chan, Director-General of the World Health Organization’s warned the world’s health ministers on Monday.
Delegates to this week’s annual meeting of the World Health Assembly (WHA) in Geneva should agree on an ambitious agenda to sharply cut the rate of newborn deaths and stillbirths over the next two decades, according to maternal and infant health experts.
The growing crisis of antibiotic resistance is catching the attention of policy-makers, but not at a fast enough rate to tackle it. More diseases are affected by resistance, meaning the bacteria cannot be killed even if different drugs are used on some patients, who then succumb.
Innovation in the pharmaceutical industry has declined drastically in the last ten years despite the high profitability of the so-called "research-based" industry, and the availability of better and more powerful science and technological tools. Not only has productivity in terms of research fallen, but the vast majority of new molecules introduced to the market do not provide new therapeutic solutions since other treatments already exist, normally at a lower cost.